Share on StockTwits
 

Analysts at Citigroup Inc. initiated coverage on shares of MedAssets (NASDAQ:MDAS) in a research report issued to clients and investors on Tuesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating on the stock.

A number of other firms have also recently commented on MDAS. Analysts at RBC Capital initiated coverage on shares of MedAssets in a research note on Thursday, February 13th. They set a “sector perform” rating and a $21.00 price target on the stock. Separately, analysts at Zacks upgraded shares of MedAssets from an “underperform” rating to a “neutral” rating in a research note on Monday, January 6th. They now have a $20.50 price target on the stock. Finally, analysts at JPMorgan Chase & Co. initiated coverage on shares of MedAssets in a research note on Monday, December 9th. They set a “neutral” rating and a $23.00 price target on the stock. Eight research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. MedAssets presently has a consensus rating of “Buy” and a consensus target price of $25.68.

Shares of MedAssets (NASDAQ:MDAS) opened at 20.99 on Tuesday. MedAssets has a one year low of $16.31 and a one year high of $26.58. The stock has a 50-day moving average of $20.97 and a 200-day moving average of $22.53. The company has a market cap of $1.299 billion and a P/E ratio of 255.60.

MedAssets, Inc (NASDAQ:MDAS) provides technology-enabled products and services.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.